Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel.
Saved in:
| Title: | Nomogram predicting individual survival following recurrence in advanced stage high-grade ovarian cancer from NRG Oncology/Gynecologic Oncology Group randomized trials of platinum and paclitaxel. |
|---|---|
| Authors: | Rose, P.G.1, Java, J.2, O'Malley, D.M.3, Geller, M.A.4, Muggia, F.M.5, Armstrong, D.K.6, Bookman, M.A.7, Brady, M.F.8, Copeland, L.J.9 |
| Source: | Gynecologic Oncology. Jun2017 Supplement 1, Vol. 145, p61-61. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00908258 |
|---|---|
| DOI: | 10.1016/j.ygyno.2017.03.147 |
